Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

Advisory Routine safety information
Warning Urgent safety information
Recall Urgent safety information relating to a product recall
Publications General safety information provided by the HPRA for publication via 3rd parties e.g. EMA

Order by:

Show:

Date	Title	Type
24/03/2023	Reporting of suspected cases of lack of efficacy to wormers and other anti-parasitic veterinary medicines	Advisory
04/02/2023	Use of teat sealants in cows at drying off	Advisory
24/11/2022	Reminder – withdrawal of veterinary medicines containing zinc oxide	Advisory
22/09/2022	Reporting of suspected cases of lack of efficacy to wormers and other anti-parasitic veterinary medicines	Advisory
05/08/2022	Batch Recall Notice for Veterinary Medicine Zerofen 22 % Granules, VPA 10987/140/001	Recall
25/07/2022	Update to safety warnings in product information leaflet for Hiprabovis IBR Marker Live Vaccine	Advisory
14/01/2022	Changes relating to target species, indications and posology for Ronaxan and its generics that are administered to cats and dogs	Advisory
12/01/2022	Change in withdrawal periods and restriction to route of administration in food-producing animals treated with injectable veterinary medicines containing Vitamin A	Advisory
06/12/2021	Batch Recall Notice for Veterinary Medicine: Marbox 100mg/ml solution for injection for cattle and pigs, VPA10815/014/001	Recall
30/08/2021	Batch Recall Notice for Veterinary Medicine: Ketofen 10% Solution for Injection, VPA10815/051/001	Advisory